Author: Lilly Matson

2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer.

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.

As part of Childhood Cancer Awareness Month, we spoke to 3 grandparents about their experience of having a grandchild with cancer.

The latest figures on skin cancer deaths reveal a 150% rise in skin cancer deaths since the 1970’s

We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.

We caught up with two of our researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.

Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.